Skip to Content

Vanderbilt-Ingram Cancer CenterVanderbilt-Ingram Cancer Center

 

VICC toll-free number 1-877-936-8422

Clinical Trials for Enzalutamide

1 Open Trial

Trial Type Protocol No. &
Open Date
Summary

Treatment

VICCBRE1385

03/03/2014

A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Efficacy and Safety of Enzalutamide in Combination With Exemestane in Patients with Advanced Breast Cancer That Is Estrogen or Progesterone Receptor-Positive and HER2-Normal